Patents by Inventor Etienne Severac

Etienne Severac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS
    Publication number: 20230295679
    Abstract: The present invention relates to a process for preparing an alkyl polyglucoside by enzymatic catalysis, using sucrose or an analogue thereof as substrate and making it possible to obtain a large diversity of alkyl polyglucosides in terms of size and structure of the glucoside part thereof, making possible the obtaining of an alkyl polyglucoside with a number of glucosyl units that can be adjusted from 2 to 200 glucosyl units. The process also makes it possible to adjust the linear or branched structure of the carbohydrate part of the alkyl polyglucoside obtained, and also the nature of the glycosidic bonds linking the glucose residues within the carbohydrate part.
    Type: Application
    Filed: July 2, 2021
    Publication date: September 21, 2023
    Applicants: INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE, Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Etienne SEVERAC, Claire MOULIS, David GUIEYSSE, Sandrine MOREL, Magali REMAUD-SIMEON
  • Protein with dextran-saccharase activity, and uses
    Patent number: 10316300
    Abstract: The invention relates to: —a protein having dextran-saccharase activity and the sequence SEQ ID NO: 1 for an amino acid sequence; —a protein having dextran-saccharase activity and the sequence SEQ ID NO: 2 for an amino acid sequence; —a complex containing a substrate and a protein with dextran-saccharase activity —a method for synthesizing dextrans; and —dextrans. The invention also relates to a method for synthesizing gluco-oligosaccharides and gluco-conjugates and to the resulting products.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: June 11, 2019
    Assignees: INSTITUT NATIONAL DES SCIENCES APPLIQUEES TOULOUSE, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PAUL SABATIER TOULOUSE III
    Inventors: Marlène Vuillemin, Marion Claverie, Claire Moulis, Magali Remaud-Simeon, Pierre Monsan, Etienne Severac, Catherine Fontagne-Faucher
  • PROTEIN WITH DEXTRAN-SACCHARASE ACTIVITY, AND USES
    Publication number: 20170247669
    Abstract: The invention relates to: a protein having dextran-saccharase activity and the sequence SEQ ID NO: 1 for an no acid sequence; a protein having dextran-saccharase activity and the sequence SEQ ID NO: 2 for an amino acid sequence; a complex containing a substrate and a protein with dextran-saccharase activity a method for synthesizing dextrans; and dextrans. The invention also relates to a method for synthesizing gluco-oligosaccharides and gluco-conjugates and to the resulting products.
    Type: Application
    Filed: July 21, 2015
    Publication date: August 31, 2017
    Inventors: Marlène Vuillemin, Marion Claverie, Claire Moulis, Magali Remaud-Simeon, Pierre Monsan, Etienne Severac, Catherine Fontagne-Faucher
  • DHA esters and use thereof in treatment and prevention of cardiovascular disease
    Patent number: 8227479
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: July 24, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Frédérique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • DHA esters and use thereof in treatment and prevention of cardiovascular disease
    Patent number: 8034377
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 11, 2011
    Assignee: Pierre Fabre Medicament
    Inventors: Frederique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • DHA ESTERS AND USE THEREOF IN TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE
    Publication number: 20110237613
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Application
    Filed: June 13, 2011
    Publication date: September 29, 2011
    Inventors: Frédérique BRUNE, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • DHA Esters and Use Thereof In Treatment and Prevention of Cardiovascular Disease
    Publication number: 20090312354
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Application
    Filed: June 22, 2007
    Publication date: December 17, 2009
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Frédérique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac